Oktober 2013 - IOZK

Autologous dendritic cell based adoptive immunotherapy of patients with colorectal cancer-A phase I-II study

2013-10-28/in Colorectal Cancer, Dendritic Cells, International Publications /von 2013-10-28 / Pathol. Oncol. Res. 2014 Apr;20(2):357-65

Tumour-derived exosomes as antigen delivery carriers in dendritic cell-based immunotherapy for malignant mesothelioma

2013-10-24/in Dendritic Cells, Exosome, International Publications, Malignant Pleural Mesothelioma /von 2013-10-24 / J Extracell Vesicles 2013;2

Dendritic cell-based immunotherapy for glioma: multiple regimens and implications in clinical trials

2013-10-21/in Dendritic Cells, Glioblastoma, International Publications /von 2013-10-21 / Neurol. Med. Chir. (Tokyo) 2013;53(11):741-54

Exploiting dendritic cells in the development of cancer vaccines

2013-10-04/in Dendritic Cells, International Publications /von 2013-10-04 / Expert Rev Vaccines 2013 Oct;12(10):1195-210

Vaccination with dendritic cell-tumor fusion cells in multiple myeloma patients: a promising strategy?

2013-10-01/in Dendritic Cells, International Publications, Multiple Myeloma /von 2013-10-01 / Immunotherapy 2013 Oct;5(10):1039-42

Temperature matters! And why it should matter to tumor immunologists

2013-10-01/in Hyperthermia, International Publications /von 2013-10-01 / Cancer Immunol Res 2013 Oct;1(4):210-6

Immunotherapy for high-grade glioma: how to go beyond Phase I/II clinical trials

2013-10-01/in Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2013-10-01 / Immunotherapy 2013 Oct;5(10):1043-6

A review of dendritic cell therapy for cancer: progress and challenges

2013-10-01/in Dendritic Cells, International Publications /von 2013-10-01 / BioDrugs 2013 Oct;27(5):453-68